Sernova receives patents for Cell Pouch

Sernova Corp.

Working to cure diabetes

Dear Agoracom Family,

I want to thank all of you for your patience with us over the past 48 hours and apologize for what was admittedly a botched launch of our new site.

As you can see, we have reverted back to the previous version of the site while we address multiple forum functionality flaws that inexplicably made their way into the launch.

To this end:

1.We have identified 8 fundamental but easily fixable flaws that will be corrected in the coming week, so that you can continue to use the forums exactly as you've been accustomed to.

2.Additionally we will also be implementing a couple of design improvements to "tighten up" the look and feel of the forums.

Have a great Sunday, especially those of you like me that are celebrating Orthodox Easter ... As well as those of you who are also like me and mourning another Maple Leafs Game 7 exit ... Ugggh!

Sincerely,

George et al

Reply New Message

Prev Message Back To Forum Threaded View Next Message

nopoo2

Rank: Treasurer [?]

Points: 947 [?]

Votes: 52 Score: 2.6 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Sernova receives patents for Cell Pouch

posted on Feb 12, 2015 08:03AM

2015-02-12 06:42 ET - News Release

Dr. Philip Toleikis reports

SERNOVA IS AWARDED PATENTS IN MULTIPLE COUNTRIES FOR CELL POUCH(TM) AND THERAPEUTIC CELL TRANSPLANTATION TECHNOLOGIES

The patent offices in China, Israel, Singapore and New Zealand have issued notices of allowance and issued patents to Sernova Corp. for its patent application entitled "Methods and Devices for Cellular Transplantation."

These patents help protect Sernova's entire Cell Pouch system, including the Cell Pouch itself, as well as the Cell Pouch combined with therapeutic cells and surgical tools for cell transplantation. These issued patents, in addition to patent rights already granted or actively being pursued in other countries, will provide Sernova with patent protection through 2030.

"Patent applications on Sernova's technologies are being pursued in multiple countries around the world, and we are confident that additional patents will be granted on an international basis," stated Dr. Philip Toleikis, Sernova's president and chief executive officer.

"Potential strategic partners, including major pharmaceutical companies, place significant value in issued patents," stated Dr. Toleikis. He continued, "Since 2009, we have been relentless at carrying out our strategy to secure exclusive patent rights on our core technologies to develop an international footprint for our products."

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply